In 2018 GALVmed marks 10 years of activities focused on bringing effective livestock vaccines, medicines & diagnostics to millions of smallholder farmers in sub-Saharan Africa and South Asia
Read our GALVmed@10 report on achievements and lessons learned
Ten products have been delivered in the past decade.
Proof of concepts achieved for eight products.
A significant increase in scope and scale over a relatively short period.
The estimated value of livestock disease mortalities that has been averted is USD 167 million.
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
2019-02-20
To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock …
In July 2018, GALVmed’s partner Boehringer Ingelheim launched a new project known as The Last Mile Initiative. The project is designed to address weak distribution channels and help smallholder farmers in Africa increase their …
In a new article posted on his Gates Notes blog, Bill Gates says rearing goats can greatly boost women’s empowerment, especially in rural areas where money earned from sale of goats stays in the women’s …
